- 31.5% of product sales, or $1.7M, was recognized in Q3.
- R&D expenses rose to a healthy $14.59 million, up from $11.6 million last year.
- Cash also rose to $180.7 million, up from $156.09 million last year.
Pacific Biosciences of California, Alexion Pharmaceuticals and Arena Pharmaceuticals were among the biotech stock movers in premarket trading on Thursday.
Arena Pharmaceuticals, Rigel Pharmaceuticals and Cytokinetics were among the biotech stock movers in premarket trading on Tuesday.
Here's how to trade six of the most active names on the market today.